We aimed at using experimental evolution to elucidate the mechanisms of antibiotic resistance evolution in the context of combination therapy. As a model we used the opportunistic pathogen Pseudomonas
Evolution of Pseudomonas aeruginosa to sequential treatments of piperacillin, tobramycin, and ciprofloxacin to study drug order-specific effects in evolutionary dynamics of resistance development
